3207 PmoA
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Hydrocarbons | 3 | 0.0 | 109× | not tested | |
| Organohalogen compounds | 1 | 0.0 | 89× | not tested | |
| Lipids and lipid-like molecules | 3 | 0.4 | 6.83× | not tested | |
| Organic oxygen compounds | 1 | 0.8 | 1.27× | not tested | |
| Homogeneous non-metal compounds | 1 | 0.9 | 1.18× | not tested | |
| Homogeneous metal compounds | 2 | 1.9 | 1.03× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02777 | PLC | Diundecyl Phosphatidyl Choline | 30 |
| DB03226 | ETF | Trifluoroethanol | 6 |
| DB04664 | CM5 | Cyclohexyl-pentyl-maltoside | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| D10 | DECANE | 36 |
| HXG | 1,2-dihexanoyl-sn-glycero-3-phosphocholine | 33 |
| P1O | 1,2-DIDECANOYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 30 |
| PLC | DIUNDECYL PHOSPHATIDYL CHOLINE | 30 |
| ZNmetal | ZINC ION | 6 |
| 6ER | (S)-2,3-bis(hexanoyloxy)propyl(2-(trimethylammonio)ethyl)phosphate | 3 |
| CUmetal | COPPER (II) ION | 3 |
| CU1metal | COPPER (I) ION | 3 |
| D12 | DODECANE | 3 |
| ETF | TRIFLUOROETHANOL | 3 |
| WIY | 4,4,4-trifluorobutan-1-ol | 3 |
| 6PL | (4S,7R)-4-HYDROXY-N,N,N-TRIMETHYL-9-OXO-7-[(PALMITOYLOXY)METHYL]-3,5,8-TRIOXA-4-PHOSPHAHEXACOSAN-1-AMINIUM 4-OXIDE | 1 |
| CM5 | 5-CYCLOHEXYL-1-PENTYL-BETA-D-MALTOSIDE | 1 |
| PGT | (1S)-2-{[{[(2R)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL STEARATE | 1 |